Literature DB >> 2955048

Sequential effects of prostaglandins and interferon-gamma on differentiation of CD8+ suppressor cells.

M N ElMasry, E J Fox, R R Rich.   

Abstract

We have previously demonstrated that differentiation of CD8+ Tp44- suppressor cells in pokeweed mitogen (PWM)-stimulated cultures requires soluble factors elaborated by CD4+ cells and monocytes, and that the monocyte signal for such differentiation can be replaced by prostaglandin E2 (PGE2). In this study, we explored the ability of interleukin 2 (IL 2) and interferon-gamma (IFN-gamma) to replace the CD4+ signal. When IL 2 or IFN-gamma was used at concentrations equivalent to those present in supernatants of PWM-pulsed cultures of CD4+ cells, no effect on differentiation of CD8+ cells was observed. However, a potent suppressor inducing activity was detected when IFN-gamma, but not IL 2, was mixed with supernatants derived from cultures of PWM-pulsed purified monocytes (M phi sup) or with 10(-8) M PGE2. Differentiated CD8+ suppressor cells (Ts) inhibited both PWM-stimulated proliferative response of CD4+ cells and immunoglobulin production by B cells. The signals mediated by the M phi sup or PGE2 and IFN-gamma were shown to act sequentially. That is, M phi sup or PGE2 was required initially, followed by an IFN-gamma-dependent differentiative step. These studies thus suggest a cascade of cellular interactions involving monocytes, CD4+ cells, and CD8+ Ts precursors that are required for the differentiation of CD8+ suppressor effector cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2955048

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  FcR+ and FcR- monocytes differentially secrete monokines during pokeweed mitogen-induced T-cell-monocyte interactions.

Authors:  J Pryjma; B Mytar; H Loppnow; M Ernst; M Zembala; H D Flad
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

2.  Normal mitogen-induced suppression of the interleukin-6 (IL-6) response and its deficiency in systemic lupus erythematosus.

Authors:  R J Warrington; W J Rutherford
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

3.  Immunoregulatory abnormalities in patients with pigeon breeder's disease.

Authors:  N Barquín; R Sansores; R Chapela; R Pérez-Tamayo; M Selman
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  Human suppressor T lymphocyte growth and differentiation.

Authors:  R R Rich; M N Elmasry; E J Fox
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

5.  Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma.

Authors:  T Y Chao; H Ohnishi; T M Chu
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

6.  Immunomodulatory properties of platelet factor 4: prevention of concanavalin A suppressor-induction in vitro and augmentation of an antigen-specific delayed-type hypersensitivity response in vivo.

Authors:  E O Gregg; L Yarwood; M J Wagstaffe; D S Pepper; M C Macdonald
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

7.  Characteristics of immunocompetent cells in synovial membranes from multiple sites in patients with rheumatoid arthritis.

Authors:  J G Hanly; D Pledger
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

8.  Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis.

Authors:  K E Balashov; S J Khoury; D A Hafler; H L Weiner
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

9.  Prostaglandin E2 suppresses phytohemagglutinin-induced immune responses of normal human mononuclear cells by decreasing intracellular glutathione generation, but not due to increased DNA strand breaks or apoptosis.

Authors:  C L Yu; C L Liu; C Y Tsai; K H Sun; T S Liao; W M Lin; H L Chen; H S Yu
Journal:  Agents Actions       Date:  1993-11

10.  Prostaglandin E2 selectively increases interferon gamma receptor expression on human CD8+ lymphocytes.

Authors:  M N elMasry; R R Rich
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.